Journal of the Association of Nurses in AIDS Care
Volume 19, Issue 2 , Pages 158-165 , March 2008

Virologic Response Using Directly Observed Therapy in Adolescents With HIV: An Adherence Tool

References 

  1. Christie D, Viner R. Adolescent development. British Medical Journal. 2005;330:301–304
  2. Deschamps AE, Graeve VD, van Wijngaerden E, DeSaar V, Vandamme AM, van Vaerenbergh K, et al. Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care and STDs. 2004;18:644–657
  3. Glikman D, Walsh L, Valkenburg J, Mangat D, Marcinak JF. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications. Pediatrics. 2007;119:e1142–e1148
  4. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. New England Journal of Medicine. 2001;345:1522–1528
  5. Hazra R, Gafni RI, Maldarelli F, Balis FM, Tullio AN, DeCarlo E, et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. Pediatrics. 2005;116:e846–e854
  6. Levy RW, Rayne CR, Fairley CK, Kong DC, Mijch A, Costello K, et al. Multidisciplinary HIV adherence intervention: A randomized study. AIDS Patient Care and STDs. 2004;18:728–735
  7. Martin, S.C., Elliott, D.K., Toledo-Tamula, M.A., Wolters P.L., & Wood, L.V. (2004, April). Comparison of knowledge and perceptions of responsibility for medication adherence between HIV-positive children and their caregivers. Poster session presented at the annual meeting of the Society of Pediatric Psychology Meeting, Charleston, SC.
  8. Matsui DM. Drug compliance in pediatrics: Clinical and research issues. Pediatric Clinics of North America. 1997;44:1–14
  9. Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus. Archives of Pediatrics and Adolescent Medicine. 2005;159:764–770
  10. Murphy DA, Sarr M, Durako SJ, Moscicki AB, Wilson CM, Muenz LR. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Archives of Pediatrics and Adolescent Medicine. 2003;157:249–255
  11. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. New England Journal of Medicine. 1998;338:853–860
  12. Parsons GN, Siberry GK, Parsons JK, Christensen JR, Joyner JL, Lee SL, et al. Multidisciplinary, inpatient directly observed therapy for HIV-1 infected children and adolescents failing HAART: A retrospective study. AIDS Patient Care and STDs. 2006;20:275–284
  13. Roberts GM, Wheeler JG, Tucker NC, Hackler C, Young K, Maples HD, et al. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics. 2004;114:e346–e353
  14. Van Dyke RB, Lee S, Johnson GM, Wiznia A, Mohan K, Stanley K, et al. Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109:e61
  15. Watson DC, Farley JJ. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatric Infectious Disease Journal. 1999;18:682–689
  16. Wiener L, Riekert K, Ryder C, Wood LV. Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible. AIDS Patient Care and STDs. 2004;18:527–538
  17. Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antiviral Therapy. 2004;9:743–761

PII: S1055-3290(08)00003-4

doi: 10.1016/j.jana.2007.08.003

Journal of the Association of Nurses in AIDS Care
Volume 19, Issue 2 , Pages 158-165 , March 2008

Article Tools